600771 广誉远
午间休市 10-20 11:29:56
资讯
新帖
简况
广誉远：产品包装与防伪是公司品牌建设、品质保障和消费者信任的重要环节
证券之星 · 10-14
广誉远：产品包装与防伪是公司品牌建设、品质保障和消费者信任的重要环节
股市必读：广誉远（600771）9月30日董秘有最新回复
证券之星 · 10-08
股市必读：广誉远（600771）9月30日董秘有最新回复
广誉远：聚焦基本盘业务的稳定增长与潜力业务的培育突破
证券之星 · 09-30
广誉远：聚焦基本盘业务的稳定增长与潜力业务的培育突破
广誉远：西黄丸和感冒清热颗粒已于2026年6月首次中选全国中成药联盟集中带量采购
证券之星 · 09-30
广誉远：西黄丸和感冒清热颗粒已于2026年6月首次中选全国中成药联盟集中带量采购
广誉远：公司以2025年度经审计财务报表为依据，已完成财务处理
证券之星 · 09-30
广誉远：公司以2025年度经审计财务报表为依据，已完成财务处理
广誉远（600771）9月28日主力资金净买入891.75万元
证券之星 · 09-29
广誉远（600771）9月28日主力资金净买入891.75万元
广誉远：养生酒业绩增长主要因渠道推广和场景创新持续发力
证券之星 · 09-23
广誉远：养生酒业绩增长主要因渠道推广和场景创新持续发力
广誉远：聚力打好科技创新、产品创新、渠道创新、品牌创新、数智创新五场"创新"硬仗
证券之星 · 09-23
广誉远：聚力打好科技创新、产品创新、渠道创新、品牌创新、数智创新五场"创新"硬仗
广誉远：公司立足经营基本面的持续改善
证券之星 · 09-23
广誉远：公司立足经营基本面的持续改善
广誉远：坚持“四足两翼”产品战略布局构建产品体系
证券之星 · 09-23
广誉远：坚持“四足两翼”产品战略布局构建产品体系
广誉远：销售费用率由2021年62.00%逐年降至2026年上半年45.50%
证券之星 · 09-23
广誉远：销售费用率由2021年62.00%逐年降至2026年上半年45.50%
广誉远：2026年上半年营业收入为8.24亿元，同比增长5.78%
证券之星 · 09-23
广誉远：2026年上半年营业收入为8.24亿元，同比增长5.78%
广誉远：坚定走高品质中药路线
证券之星 · 09-23
广誉远：坚定走高品质中药路线
每周股票复盘：广誉远（600771）证券事务代表因个人原因辞职
证券之星 · 09-13
每周股票复盘：广誉远（600771）证券事务代表因个人原因辞职
广誉远（600771）披露证券事务代表辞职公告，9月10日股价下跌1.35%
证券之星 · 09-10
广誉远（600771）披露证券事务代表辞职公告，9月10日股价下跌1.35%
每周股票复盘：广誉远（600771）将召开2026年半年度业绩说明会
证券之星 · 09-06
每周股票复盘：广誉远（600771）将召开2026年半年度业绩说明会
广誉远：公司未收到参会通知，因此未安排相关人员出席
证券之星 · 09-03
广誉远：公司未收到参会通知，因此未安排相关人员出席
广誉远（600771）披露召开2026年半年度业绩说明会预告公告，9月2日股价下跌1.87%
证券之星 · 09-02
广誉远（600771）披露召开2026年半年度业绩说明会预告公告，9月2日股价下跌1.87%
每周股票复盘：广誉远（600771）Q2净利增35.01%
证券之星 · 08-30
每周股票复盘：广誉远（600771）Q2净利增35.01%
广誉远（600771）2026年中报简析：营收净利润同比双双增长
证券之星 · 08-27
广誉远（600771）2026年中报简析：营收净利润同比双双增长
加载更多
公司概况
公司名称：
广誉远中药股份有限公司
所属行业：
医药制造业
上市日期：
1996-11-05
主营业务：
广誉远中药股份有限公司的主营业务是中药产品的生产与销售。公司的主要产品是中药产品。公司获得了“山西精品”认定，六味地黄丸传统制作技艺及姜炭制作技艺入选晋中市非物质文化遗产名录。
发行价格：
4.80
{"stockData":{"symbol":"600771","market":"SH","secType":"STK","nameCN":"广誉远","latestPrice":14.01,"timestamp":1792466996000,"preClose":14.16,"halted":0,"volume":4721356,"delay":0,"changeRate":-0.0106,"floatShares":488999999,"shares":488999999,"eps":0.1448,"marketStatus":"午间休市","change":-0.15,"latestTime":"10-20 11:29:56","open":14.16,"high":14.36,"low":14,"amount":66857300,"amplitude":0.0254,"askPrice":14.01,"askSize":28,"bidPrice":14,"bidSize":1399,"shortable":0,"etf":0,"ttmEps":0.1448,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792472400000},"marketStatusCode":3,"adr":0,"adjPreClose":14.16,"symbolType":"stock","openAndCloseTimeList":[[1792459800000,1792467000000],[1792472400000,1792479600000]],"highLimit":15.58,"lowLimit":12.74,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":489491141,"isCdr":false,"pbRate":4.16,"roa":"--","peRate":96.754144,"roe":"5.1%","epsLYR":0.13,"committee":0.888786,"marketValue":6858000000,"turnoverRate":0.0096,"status":1,"floatMarketCap":6858000000},"requestUrl":"/m/hq/s/600771","defaultTab":"news","newsList":[{"id":"2675317628","title":"广誉远：产品包装与防伪是公司品牌建设、品质保障和消费者信任的重要环节","url":"https://stock-news.laohu8.com/highlight/detail?id=2675317628","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675317628?lang=zh_cn&edition=full","pubTime":"2026-10-14 17:18","pubTimestamp":1791969485,"startTime":"0","endTime":"0","summary":"证券之星消息，广誉远10月14日在投资者关系平台上答复投资者关心的问题。产品包装与防伪是公司品牌建设、品质保障和消费者信任的重要环节，公司始终高度重视。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400028840.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","600771","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673571017","title":"股市必读：广誉远（600771）9月30日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2673571017","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673571017?lang=zh_cn&edition=full","pubTime":"2026-10-08 02:54","pubTimestamp":1791399249,"startTime":"0","endTime":"0","summary":"截至2026年9月30日收盘，广誉远报收于14.15元，上涨1.87%，换手率1.9%，成交量9.28万手，成交额1.31亿元。公司使用公积金弥补亏损的议案经2025年年度股东会审议通过，并按规定将相关法定程序及公示程序履行完毕。公司以2025年度经审计财务报表为依据，已完成财务处理。叠加2026年上半年经营盈利，公司2026年半年度报告中母公司未分配利润已转正为9,813.94万元。当日关注点交易信息汇总：9月30日主力资金净流入209.83万元，占总成交额1.6%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800001433.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600771","BK0188","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671027007","title":"广誉远：聚焦基本盘业务的稳定增长与潜力业务的培育突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2671027007","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671027007?lang=zh_cn&edition=full","pubTime":"2026-09-30 17:45","pubTimestamp":1790761524,"startTime":"0","endTime":"0","summary":"建议优化高管团队，引进市场实战人才，调整考核导向，建立容错机制，平衡风控与业务拓展，把品牌古方优势转化为业绩增量。下一阶段，公司将在坚守合规底线的前提下，探索经营创新模式与容错机制，平衡风控要求与业务拓展动能；聚焦基本盘业务的稳定增长与潜力业务的培育突破，推动渠道布局稳步落地，促进品牌资产与古方优势等核心壁垒持续转化为经营业绩。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000028591.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","600771","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671808208","title":"广誉远：西黄丸和感冒清热颗粒已于2026年6月首次中选全国中成药联盟集中带量采购","url":"https://stock-news.laohu8.com/highlight/detail?id=2671808208","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671808208?lang=zh_cn&edition=full","pubTime":"2026-09-30 17:45","pubTimestamp":1790761523,"startTime":"0","endTime":"0","summary":"证券之星消息，广誉远09月30日在投资者关系平台上答复投资者关心的问题。请问西黄丸与感冒清热颗粒已经进院没有，销量怎么样？公司产品“西黄丸和感冒清热颗粒”已于2026年6月首次中选全国中成药联盟集中带量采购，为该类产品院内渠道拓展奠定了根本基础。目前公司正紧跟各省份集采落地节奏，有序推进全国各市场医疗端落地工作，具体销量请以官方信息为准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000028589.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0077","600771","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671520887","title":"广誉远：公司以2025年度经审计财务报表为依据，已完成财务处理","url":"https://stock-news.laohu8.com/highlight/detail?id=2671520887","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671520887?lang=zh_cn&edition=full","pubTime":"2026-09-30 17:45","pubTimestamp":1790761522,"startTime":"0","endTime":"0","summary":"证券之星消息，广誉远(600771)09月30日在投资者关系平台上答复投资者关心的问题。投资者提问：贵司关于使用公积金弥亏事项，经过股东大会审议通过，且公示时间也已经早到期了，为什么迟迟没有进行财务调整？广誉远回复：您好！感谢您的关注。公司使用公积金弥补亏损的议案经2025年年度股东会审议通过，并按规定将相关法定程序及公示程序履行完毕。公司以2025年度经审计财务报表为依据，已完成财务处理。叠加2026年上半年经营盈利，公司2026年半年度报告中母公司未分配利润已转正为9,813.94万元。具体详见公司定期报告。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000028585.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","600771","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671661072","title":"广誉远（600771）9月28日主力资金净买入891.75万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671661072","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671661072?lang=zh_cn&edition=full","pubTime":"2026-09-29 08:18","pubTimestamp":1790641127,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月28日收盘，广誉远报收于14.04元，上涨2.86%，换手率2.79%，成交量13.66万手，成交额1.91亿元。近5日资金流向一览见下表：广誉远融资融券信息显示，融资方面，当日融资买入1800.41万元，融资偿还1272.88万元，融资净买入527.53万元。广誉远主营业务：中药产品的生产、销售,包括传统中药、精品中药和养生酒三大板块。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900007020.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","600771","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669810115","title":"广誉远：养生酒业绩增长主要因渠道推广和场景创新持续发力","url":"https://stock-news.laohu8.com/highlight/detail?id=2669810115","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669810115?lang=zh_cn&edition=full","pubTime":"2026-09-23 17:06","pubTimestamp":1790154368,"startTime":"0","endTime":"0","summary":"证券之星消息，广誉远09月23日在投资者关系平台上答复投资者关心的问题。相关经营数据信息公司已按照信披规范要求在定期报告中披露，养生酒包含加味龟龄集酒和远字牌龟龄集酒，该板块的业绩增长主要原因为公司结合不同产品渠道和客群特点，在渠道推广和场景创新方面持续发力。营销强化方面，不断探索迭代养生酒运营模式，探索新的推广场景。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300028883.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600771","BK0188","BK0077","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669101135","title":"广誉远：聚力打好科技创新、产品创新、渠道创新、品牌创新、数智创新五场\"创新\"硬仗","url":"https://stock-news.laohu8.com/highlight/detail?id=2669101135","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669101135?lang=zh_cn&edition=full","pubTime":"2026-09-23 17:06","pubTimestamp":1790154366,"startTime":"0","endTime":"0","summary":"投资者提问：有长期关注广誉远的投资者在论坛中写道：公司手捧\"五百年非遗传承、国家保密配方、稀缺老字号\"三张底牌，是中医药赛道里难得的珍宝，但管理层\"没有容人之量，没有用人之贤，没有企业规划，没有管理能力\"，广誉远\"就败在了他手中\"。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300028878.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","BK0188","600771"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669016431","title":"广誉远：公司立足经营基本面的持续改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2669016431","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669016431?lang=zh_cn&edition=full","pubTime":"2026-09-23 16:57","pubTimestamp":1790153835,"startTime":"0","endTime":"0","summary":"证券之星消息，广誉远09月23日在投资者关系平台上答复投资者关心的问题。公司董事长依法履行其法定职责，统筹公司战略方向与经营发展全局，其履职情况均与公司核心指标相挂钩，受证监会、交易所、上级单位等多方面监管与考核。公司立足经营基本面的持续改善，围绕“价值创造、价值经营、价值实现”推进市值管理。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300028611.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","600771","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669101641","title":"广誉远：坚持“四足两翼”产品战略布局构建产品体系","url":"https://stock-news.laohu8.com/highlight/detail?id=2669101641","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669101641?lang=zh_cn&edition=full","pubTime":"2026-09-23 16:57","pubTimestamp":1790153832,"startTime":"0","endTime":"0","summary":"证券之星消息，广誉远09月23日在投资者关系平台上答复投资者关心的问题。公司坚持“四足两翼”产品战略布局构建产品体系，已形成以四大核心主导品种为引领，多个在产在销常规品种为支撑的梯次化产品结构。根据国家《中医药振兴发展“十五五”规划》及中药行业发展趋势，公司将构建医疗与大健康协同发展的产业格局。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300028609.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0188","BK0239","600771"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669640101","title":"广誉远：销售费用率由2021年62.00%逐年降至2026年上半年45.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669640101","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669640101?lang=zh_cn&edition=full","pubTime":"2026-09-23 16:54","pubTimestamp":1790153650,"startTime":"0","endTime":"0","summary":"广誉远公司2025年营收13.69亿，同比增长很低，毛利高达9.254亿，扣非净利区区仅6073.74万，销售费用率46.62%显著高于同行。当前，公司处于产品价值驱动向品牌价值驱动转型期，公司持续加大销售费用管控力度，通过归拢渠道至头部商业、TOP连锁战略合作、强化预算管控与投入产出分析评价、压降低效投入等举措，费用管控成效显现，销售费用率由2021年62.00%逐年降至2026年上半年45.50%，费效比呈逐步改善态势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300028541.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600771","BK0077","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669810169","title":"广誉远：2026年上半年营业收入为8.24亿元，同比增长5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669810169","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669810169?lang=zh_cn&edition=full","pubTime":"2026-09-23 16:54","pubTimestamp":1790153649,"startTime":"0","endTime":"0","summary":"证券之星消息，广誉远09月23日在投资者关系平台上答复投资者关心的问题。近年来公司经营质量持续改善，内部管理基础夯实，各项经营指标不断改善，2026年上半年，公司营业收入为8.24亿元，同比增长5.78%，归母净利润为8465.73万元，同比增长10.15%，核心业务增长动能正逐步释放。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300028539.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600771"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669210166","title":"广誉远：坚定走高品质中药路线","url":"https://stock-news.laohu8.com/highlight/detail?id=2669210166","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669210166?lang=zh_cn&edition=full","pubTime":"2026-09-23 16:54","pubTimestamp":1790153649,"startTime":"0","endTime":"0","summary":"证券之星消息，广誉远09月23日在投资者关系平台上答复投资者关心的问题。公司已通过股份回购、高管增持等各类举措的落地，及时传递公司及管理层发展信心。目前公司经营现金流良性，资产负债结构良性，合规经营，规范信披，坚定走高品质中药路线，坚守守正创新，切实维护全体股东合法权益。未来，我们将不断改善经营质量，回应每一位投资者的信任与支持。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300028540.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600771","BK0188","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667074635","title":"每周股票复盘：广誉远（600771）证券事务代表因个人原因辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2667074635","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667074635?lang=zh_cn&edition=full","pubTime":"2026-09-13 02:24","pubTimestamp":1789237454,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，广誉远报收于13.5元，较上周的13.73元下跌1.68%。本周关注点公司公告汇总：证券事务代表乔莉因个人原因辞职，工作已完成交接。公司公告汇总广誉远中药股份有限公司董事会近日收到公司证券事务代表乔莉女士递交的书面辞职报告。截至公告披露日，乔莉女士未持有公司股份，不存在应当履行而未履行的承诺事项。公司将根据相关规定尽快聘任新的证券事务代表。公司及董事会对乔莉女士在任职期间的贡献表示感谢。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300000610.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0077","161027","600771"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666859499","title":"广誉远（600771）披露证券事务代表辞职公告，9月10日股价下跌1.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666859499","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666859499?lang=zh_cn&edition=full","pubTime":"2026-09-10 22:49","pubTimestamp":1789051752,"startTime":"0","endTime":"0","summary":"截至2026年9月10日收盘，广誉远报收于13.85元，较前一交易日下跌1.35%，最新总市值为67.79亿元。公告显示，公司董事会近日收到证券事务代表乔莉女士递交的书面辞职报告。乔莉女士因个人原因申请辞去公司证券事务代表职务，其辞职报告自送达公司董事会之日起生效。截至公告披露日，乔莉女士未持有公司股份，不存在应当履行而未履行的承诺事项。公司将根据相关规定尽快聘任新的证券事务代表。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000042678.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600771","BK0239","BK0077","161027","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665366601","title":"每周股票复盘：广誉远（600771）将召开2026年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2665366601","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665366601?lang=zh_cn&edition=full","pubTime":"2026-09-06 03:34","pubTimestamp":1788636852,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，广誉远报收于13.73元，较上周的13.98元下跌1.79%。本周，广誉远8月31日盘中最高价报13.98元。广誉远当前最新总市值67.21亿元，在中药板块市值排名29/66，在两市A股市值排名2515/5214。本周关注点公司公告汇总：广誉远将于2026年9月9日召开半年度业绩说明会，介绍上半年经营成果与财务指标。公司公告汇总广誉远中药股份有限公司将于2026年9月9日15:00-16:00通过网络互动方式召开2026年半年度业绩说明会，会议将在价值在线平台举行。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600001220.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600771","BK0188","BK0077","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664878107","title":"广誉远：公司未收到参会通知，因此未安排相关人员出席","url":"https://stock-news.laohu8.com/highlight/detail?id=2664878107","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664878107?lang=zh_cn&edition=full","pubTime":"2026-09-03 17:21","pubTimestamp":1788427268,"startTime":"0","endTime":"0","summary":"证券之星消息，广誉远09月03日在投资者关系平台上答复投资者关心的问题。公司未收到参会通知，因此未安排相关人员出席。公司始终结合业务发展需求，主动参与官方及行业权威机构组织的重要会议和产业交流活动，后续将持续关注山西省中医药产业发展动态，积极参与相关行业对接活动。相关经营信息请以公司官方披露为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300031014.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","600771","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664389013","title":"广誉远（600771）披露召开2026年半年度业绩说明会预告公告，9月2日股价下跌1.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664389013","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664389013?lang=zh_cn&edition=full","pubTime":"2026-09-02 17:27","pubTimestamp":1788341262,"startTime":"0","endTime":"0","summary":"截至2026年9月2日收盘，广誉远报收于13.65元，较前一交易日下跌1.87%，最新总市值为66.82亿元。该股当日开盘13.91元，最高13.91元，最低13.62元，成交额达8279.31万元，换手率为1.23%。近日，广誉远中药股份有限公司发布关于召开2026年半年度业绩说明会的预告公告。公告显示，公司将于2026年9月9日15:00-16:00通过网络互动方式召开2026年半年度业绩说明会，会议将在价值在线平台举行。投资者可于2026年9月7日15:00前通过指定链接或微信小程序提交问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200030945.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600771","BK0077","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663804580","title":"每周股票复盘：广誉远（600771）Q2净利增35.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663804580","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663804580?lang=zh_cn&edition=full","pubTime":"2026-08-30 09:04","pubTimestamp":1788051853,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，广誉远报收于13.98元，较上周的13.44元上涨4.02%。股本股东变化截至2026年6月30日，广誉远股东户数为6.16万户，较3月31日减少4363.0户，减幅为6.62%。公司公告汇总广誉远中药股份有限公司2026年半年度报告摘要显示，截至报告期末，公司总资产为2,532,407,757.14元，较上年度末增长3.92%；归属于上市公司股东的净资产为1,667,344,475.10元，同比增长2.12%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000004508.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0188","BK0239","600771"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662740988","title":"广誉远（600771）2026年中报简析：营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2662740988","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662740988?lang=zh_cn&edition=full","pubTime":"2026-08-27 06:06","pubTimestamp":1787781991,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期广誉远发布2026年中报。根据财报显示，广誉远营收净利润同比双双增长。截至本报告期末，公司营业总收入8.24亿元，同比上升5.78%，归母净利润8465.73万元，同比上升10.15%。按单季度数据看，第二季度营业总收入3.36亿元，同比下降7.19%，第二季度归母净利润1791.92万元，同比上升35.01%。财报体检工具显示：建议关注公司现金流状况建议关注公司应收账款状况本文数据来源于广誉远2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700010948.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600771"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1792468658683,"stockEarnings":[{"period":"1week","weight":0.0064},{"period":"1month","weight":0.0321},{"period":"3month","weight":-0.0426},{"period":"6month","weight":-0.2125},{"period":"1year","weight":-0.2551},{"period":"ytd","weight":-0.2125}],"compareEarnings":[{"period":"1week","weight":-0.0175},{"period":"1month","weight":-0.0463},{"period":"3month","weight":-0.0345},{"period":"6month","weight":-0.0914},{"period":"1year","weight":-0.0283},{"period":"ytd","weight":-0.0599}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广誉远中药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"61557人(较上一季度减少6.62%)","perCapita":"7951股","listingDate":"1996-11-05","address":"山西省晋中市太谷区广誉远路1号","registeredCapital":"48949万元","survey":" 广誉远中药股份有限公司的主营业务是中药产品的生产与销售。公司的主要产品是中药产品。公司获得了“山西精品”认定，六味地黄丸传统制作技艺及姜炭制作技艺入选晋中市非物质文化遗产名录。","listedPrice":4.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"广誉远(600771)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供广誉远(600771)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"广誉远,600771,广誉远股票,广誉远股票老虎,广誉远股票老虎国际,广誉远行情,广誉远股票行情,广誉远股价,广誉远股市,广誉远股票价格,广誉远股票交易,广誉远股票购买,广誉远股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"广誉远(600771)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供广誉远(600771)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}